Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.01
0.021.99%
At close: -
$1.01
0.000.00%
After Hours: Mar 28, 7:02 PM EDT
Comments
Loading...
Opus Genetics Analyst Ratings and Price Targets | NASDAQ:IRD | Benzinga
Opus Genetics Inc has a consensus price target of $8 based on the ratings of 1 analysts. The high is $8 issued by HC Wainwright & Co. on February 19, 2025. The low is $8 issued by HC Wainwright & Co. on February 19, 2025. The 2 most-recent analyst ratings were released by HC Wainwright & Co. on February 19, 2025 and December 12, 2024, respectively. With an average price target of $8 between HC Wainwright & Co., there's an implied 692.08% upside for Opus Genetics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Opus Genetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | Buy Now | 692.08% | HC Wainwright & Co. | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 692.08% | HC Wainwright & Co. | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Opus Genetics (IRD) stock?
The latest price target for Opus Genetics (NASDAQ:IRD) was reported by HC Wainwright & Co. on February 19, 2025. The analyst firm set a price target for $8.00 expecting IRD to rise to within 12 months (a possible 692.08% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Opus Genetics (IRD)?
The latest analyst rating for Opus Genetics (NASDAQ:IRD) was provided by HC Wainwright & Co., and Opus Genetics reiterated their buy rating.
When was the last upgrade for Opus Genetics (IRD)?
There is no last upgrade for Opus Genetics
When was the last downgrade for Opus Genetics (IRD)?
There is no last downgrade for Opus Genetics.
When is the next analyst rating going to be posted or updated for Opus Genetics (IRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Opus Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Opus Genetics was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.
Is the Analyst Rating Opus Genetics (IRD) correct?
While ratings are subjective and will change, the latest Opus Genetics (IRD) rating was a reiterated with a price target of $8.00 to $8.00. The current price Opus Genetics (IRD) is trading at is $1.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.